Drugs banned in other countries, still prevailing in India, a vital matter of concern—A narrative review

R. Sangeetha, K. Charan, B. Santana, M. Kumari, P. Murali, G. Priya
{"title":"Drugs banned in other countries, still prevailing in India, a vital matter of concern—A narrative review","authors":"R. Sangeetha, K. Charan, B. Santana, M. Kumari, P. Murali, G. Priya","doi":"10.4103/jdrntruhs.jdrntruhs_134_22","DOIUrl":null,"url":null,"abstract":"Drugs and their formulations are mainly used in the prevention and treatment of disease or disorders; out of such drugs, only some are considered to be essential and life-saving, whereas others remain substitutes for each other. When some serious adverse effect is faced by a general population on the consumption of the particular drug, the adverse side effects are monitored through pharmacovigilance; when the hazard overshadows the benefit, then the drug is proposed for a ban in the country. Some drugs potentiate the adverse effect only when it is in combination with another drug, which is considered to be irrational; in such situations, the Fixed Dose Combinations FDC is banned but not the single drug. Banned drugs are still available in India, and this might be due to the lack of awareness and knowledge among clinicians and the persistence of loopholes in Indian laws governing the approval and manufacture of drugs. The government needs to enforce laws and increase drug information centers and ensure their proper functioning, from where the update on each drug will be provided to doctors and the general population.","PeriodicalId":15571,"journal":{"name":"Journal of Dr. NTR University of Health Sciences","volume":"42 1","pages":"259 - 264"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dr. NTR University of Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jdrntruhs.jdrntruhs_134_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Drugs and their formulations are mainly used in the prevention and treatment of disease or disorders; out of such drugs, only some are considered to be essential and life-saving, whereas others remain substitutes for each other. When some serious adverse effect is faced by a general population on the consumption of the particular drug, the adverse side effects are monitored through pharmacovigilance; when the hazard overshadows the benefit, then the drug is proposed for a ban in the country. Some drugs potentiate the adverse effect only when it is in combination with another drug, which is considered to be irrational; in such situations, the Fixed Dose Combinations FDC is banned but not the single drug. Banned drugs are still available in India, and this might be due to the lack of awareness and knowledge among clinicians and the persistence of loopholes in Indian laws governing the approval and manufacture of drugs. The government needs to enforce laws and increase drug information centers and ensure their proper functioning, from where the update on each drug will be provided to doctors and the general population.
在其他国家被禁止的毒品在印度仍然盛行,这是一个至关重要的问题
药品及其制剂主要用于预防和治疗疾病或失调;在这些药物中,只有一些被认为是必不可少的和挽救生命的,而其他药物则是相互替代的。当一般人群在使用特定药物时面临严重不良反应时,通过药物警戒监测不良副作用;当危害超过益处时,这种药物就会被提议在该国禁用。有些药物只有在与另一种药物合用时才会加剧不良反应,这被认为是不合理的;在这种情况下,固定剂量组合FDC被禁止,但单一药物不被禁止。在印度仍然可以买到违禁药物,这可能是由于临床医生缺乏意识和知识,以及印度管理药物批准和生产的法律一直存在漏洞。政府需要加强执法,增加药物信息中心,并确保其正常运作,从那里向医生和普通民众提供每种药物的最新信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
14
审稿时长
35 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信